Clinical Trial Update: Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 long-term safety study of CP-464,005 inhaled insulin in Japanese patients with Type 1 or Type 2 diabetes was terminated; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• CP-464,005 inhaler (insulin inhalation formulation CP-464,005)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1 | Phase 3 | Status: TERMINATED | Results posted: 2009-10-05